Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

NCT07060638 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Alcohol-associated Hepatitis

Interventions

DRUG: IL-22
DRUG: Prednisone
DRUG: Acamprosate
DRUG: Prednisone placebo
DRUG: IL-22 (F-652) Placebo
BEHAVIORAL: Motivational Interviewing (MI)
BEHAVIORAL: Motivational Enhancement Therapy (MET)
BEHAVIORAL: Usual Care

Sponsor

Samer Gawrieh

Collaborators

[object Object]